Eton Pharmaceuticals Inc.

Last updated September 27, 2026

Organization details

Legal name
Eton Pharmaceuticals Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Deer Park
Headquarters state / province
Illinois
Headquarters country
United States
Fiscal year end
December
Ticker symbol
ETON
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001710340
EIN
37-1858472

Board of directors

Chief executives

Sean Brynjelsen · President & CEO
Dates unknown

Director election results

Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 4 other boards. 3 are in the same sector.

Network of Eton Pharmaceuticals Inc.'s board connections GT Biopharma Inc. GT Biopharma Inc. GridAI Technologies Corp. GridAI Technologies Co... Jazz Pharmaceuticals plc Jazz Pharmaceuticals p... Relmada Therapeutics Inc. Relmada Therapeutics I... Charles J. Casamento Charles J. Casamento Norbert G. Riedel Norbert G. Riedel Eton Pharmaceuticals Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$30,753,955
29 sales by 6 insiders
Date Insider Transaction Shares Price Value
Nov 10, 2026 Charles J. Casamento Director Option exercise +12,500 $7.31 $91,375
Nov 10, 2026 Charles J. Casamento Director Option exercise +27,400 $3.58 $98,092
Nov 10, 2026 Charles J. Casamento Director Option exercise +19,655 $8.61 $169,230
Nov 10, 2026 Charles J. Casamento Director Option exercise +21,000 $3.78 $79,380
Nov 10, 2026 Charles J. Casamento Director Open-market sale −6,380 $64.33 $410,417
Nov 10, 2026 Charles J. Casamento Director Open-market sale −14,715 $65.32 $961,256
Nov 10, 2026 Charles J. Casamento Director Open-market sale −22,601 $66.26 $1,497,576
Nov 10, 2026 Charles J. Casamento Director Open-market sale −33,956 $67.11 $2,278,797
Nov 10, 2026 Charles J. Casamento Director Open-market sale −2,903 $67.87 $197,025
Oct 6, 2026 Krempa David Officer (Chief Business Officer) Open-market sale −4,166 $55.07 $229,406
Oct 2, 2026 Krempa David Officer (Chief Business Officer) Option exercise +10,522 — —
Aug 28, 2026 Paul Maier V Director Option exercise +50,000 $3.78 $189,000
Aug 28, 2026 Paul Maier V Director Open-market sale −36,387 $58.64 $2,133,734
Aug 28, 2026 Paul Maier V Director Open-market sale −13,485 $60.21 $811,932
Aug 28, 2026 Paul Maier V Director Open-market sale −128 $61.77 $7,907

Organizations in the same sector, closest in location and size first.

Questions about Eton Pharmaceuticals Inc.

Who is the CEO of Eton Pharmaceuticals Inc.?

Sean Brynjelsen is Eton Pharmaceuticals Inc.'s President & CEO.

How many directors are on Eton Pharmaceuticals Inc.'s board?

Eton Pharmaceuticals Inc.'s board has 5 directors: Charles J. Casamento, Jennifer McKie Adams, Norbert G. Riedel, Paul Maier V and Sean Brynjelsen.

Are Eton Pharmaceuticals Inc. insiders buying or selling shares?

Over the last 12 months, Eton Pharmaceuticals Inc. insiders made no open-market purchases and sold $30.8 million of shares in 29 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="eton-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.